Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00975923 · ClinicalTrials.gov registry record · NA

Safe Critical Care: Testing Improvement Strategies

A NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI), sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT00975923 is a NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI) that has completed, run by Vanderbilt University. The registered enrollment target is 59 participants, below the 108-participant average among 7 other Ventilator Associated Pneumonia trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00975923, a NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI), has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

One group of hospitals participated in a collaborative approach for healthcare quality improvement while another group was provided only a tool kit. The investigators' objective was to determine if the Collaborative would perform better at preventing central line-associated bloodstream infections (CLABSI) and ventilator-associated pneumonias (VAP). Hospitals were randomized to the Tool Kit or Collaborative conditions. The investigators' study evaluated the effects on care processes and outcomes of a multi-institutional quality improvement initiative focused on preventing hospital associate infections. The investigators' hypothesis was that the strategies for implementing safe critical care practice will differ in level of achievement whereby the Collaborative group will perform better than the Tool Kit group. The outcome measure comprised clinical event rates and an index of safe practices that represent a bundling of key process measures related to evidence-based practices for preventing catheter-related blood-stream infections and ventilator-associated pneumonia in the intensive care unit.

Conditions Studied

Ventilator Associated Pneumonia Central Line-Associated Bloodstream Infection (CLABSI)

Interventions

  • BEHAVIORAL Collaborative Group
  • BEHAVIORAL Tool Kit

Study Locations (1)

Tennessee

  • HCA Hospital Corporation of America - Nashville

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2006-02
Est. Completion 2008-04
Phase NA

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00975923

The ClinicalTrials.gov registry entry for NCT00975923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108-participant average among 7 other Ventilator Associated Pneumonia trials with a reported enrollment target (45% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ventilator Associated Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Group is the first listed.

NCT00975923 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00975923 about?

NCT00975923 is a clinical study titled "Safe Critical Care: Testing Improvement Strategies". One group of hospitals participated in a collaborative approach for healthcare quality improvement while another group was provided only a tool kit. The investigators' objective was to determine if the Collaborative would perform better at preventing central line-associated bloodstream infections (C...

What is the current status of trial NCT00975923?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2006-02. Estimated completion is 2008-04.

What conditions does trial NCT00975923 study?

This clinical trial studies the following conditions: Ventilator Associated Pneumonia, Central Line-Associated Bloodstream Infection (CLABSI).

What interventions are being tested in trial NCT00975923?

The interventions under investigation include: Collaborative Group (BEHAVIORAL), Tool Kit (BEHAVIORAL).

Who is sponsoring clinical trial NCT00975923?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00975923 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventilator Associated Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventilator Associated Pneumonia

All registered trials for this condition

Central Line-Associated Bloodstream Infection (CLABSI)

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.